BioCentury
ARTICLE | Emerging Company Profile

Scratching the surface

Oppilotech’s model finds new targets for Gram-negative antibiotic potentiators

June 1, 2018 10:11 PM UTC

Oppilotech Ltd. is using computational modeling to develop first-in-class compounds that can permeate the lipopolysaccharide layer of the outer cell membrane of Gram-negative bacteria to potentiate existing antibiotics.

Marketed polymyxins are used to disrupt the lipopolysaccharide (LPS) to treat Gram-negative infections, but they have neurotoxic and nephrotoxic side effects that limit use to last resort cases. ...

BCIQ Company Profiles

Oppilotech Ltd.

BCIQ Target Profiles

Lipopolysaccharide (LPS)